Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Roy D. Baynes files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Steven Leonard Chapman - $93.37M of NTRA open-market activity in the last 12 months
- Matthew Rabinowitz - $82.72M of NTRA open-market activity in the last 12 months
- Roelof Botha - $34.89M of NTRA open-market activity in the last 12 months
- Daniel Rabinowitz - $23.83M of NTRA open-market activity in the last 12 months
- Michael Burkes Brophy - $22.14M of NTRA open-market activity in the last 12 months
- Jonathan Sheena - $21.09M of NTRA open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Roy D. Baynes?
Roy D. Baynes is a corporate insider, tracked as Director of Aardvark Therapeutics, Inc. (AARD). InsiderAlpha holds 18 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Roy D. Baynes submitted recently?
3 primary Form 4 filings in the last 90 days, covering 3 companies.
Has Roy D. Baynes been buying or selling stock?
Recorded transactions: 0 open-market purchases and 20 open-market sales ($10.80M) across all tracked filings.
Where can I see all of Roy D. Baynes's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Roy D. Baynes and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
